Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation

Shin-Yeu Ong, MD MRCP, MSE, Ha Thi Thu Truong, BSc, Aloysius Y Ho, Yeh Ching Linn, MRCP, Yeow-Tee YT Goh, MD, Colin Phipps Diong, Yvonne Loh, MBBS, MRCP, William YK Hwang, FRCP, FAMS, MMed, MRCP, MBBS

Blood (2014) 124 (21): 1098.

https://doi.org/10.1182/blood.V124.21.1098.1098

Published: 2014

Journal Articles

Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML

Pramila Krishnamurthy, Victoria T Potter, MBBS, FRCPA, FRACP, ZiYi Lim, Austin G Kulasekararaj, Aloysius Y Ho, Judith C. W. Marsh, Prof MD PhD, Robin M. Ireland, FRCP, FRCPath, Stephen Devereux, FRCP, FRCPath, PhD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 660.

https://doi.org/10.1182/blood.V118.21.660.660

Published: 2011

Journal Articles

Effect of Time to Dasatinib Initiation On Outcome of Imatinib-Intolerant Patients with Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Results From a European Observational Study (FORTE; CA180–211)

David Marin, Enrica Morra, MD, Mauricette Michallet, Andrzej Hellmann, MD, Dietger Niederwieser, MD, Ernst Schloegl, MD, Mats Björeman, MD, Kajetana Foryciarz, MD, PhD, Aloysius Y Ho, Kazimierz Kuliczkowski, Gert Ossenkoppele, MD, PhD, Antonella Gozzini, MD, M. Lurdes Guerra, MD, Gregor Verhoef, Ave Mori, MD, Miranda Pans, Marc van Baardewijk, Pharm.D, Juan Luis Steegmann, MD, PhD

Blood (2011) 118 (21): 1689.

https://doi.org/10.1182/blood.V118.21.1689.1689

Published: 2011

Journal Articles

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

Judith C. Marsh, Vikas Gupta, ZiYi Lim, Aloysius Y. Ho, Robin M. Ireland, Janet Hayden, Victoria Potter, Mickey B. Koh, M. Serajul Islam, Nigel Russell, David I. Marks, Ghulam J. Mufti, Antonio Pagliuca

Blood (2011) 118 (8): 2351–2357.

https://doi.org/10.1182/blood-2010-12-327536

Published: 2011

Includes: Supplemental data

Journal Articles

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML).

Shreyans A Gandhi, MBBS, MD, DNB, MRCP, Victoria T Potter, BSc, MBBS, Victoria J. Tindell, MBChB, Rachel Kesse-Adu, MBBS, Laura Reiff-Zall, Michelle Kenyon, Judith C. W. Marsh, MD, Aloysius Y Ho, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, ZiYi Lim, MD

Blood (2010) 116 (21): 1304.

https://doi.org/10.1182/blood.V116.21.1304.1304

Published: 2010

Journal Articles

Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT

Victoria J Tindell, MBChB, Victoria T Potter, BSc, MBBS, Rachel Kesse-Adu, MBBS, Laura Reiff-Zall, Aloysius Y Ho, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Judith C. W. Marsh, MD, ZiYi Lim, MD

Blood (2010) 116 (21): 1331.

https://doi.org/10.1182/blood.V116.21.1331.1331

Published: 2010

Journal Articles

Polycomb Complex Group Gene Mutations and Their Prognostic Relevance In 5-Azacitidine Treated Myelodysplastic Syndrome Patients

Blood (2010) 116 (21): 125.

https://doi.org/10.1182/blood.V116.21.125.125

Published: 2010

Journal Articles

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Victoria T Potter, BSc, MBBS, Victoria J Tindell, MBChB, Rachel Kesse-Adu, MBBS, Janet Hayden, Patience Pasipanodya, Laura Reiff-Zall, Judith C. W. Marsh, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Aloysius Y Ho, ZiYi Lim, MD, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2010) 116 (21): 2375.

https://doi.org/10.1182/blood.V116.21.2375.2375

Published: 2010

NARROW

Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation

Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML

Effect of Time to Dasatinib Initiation On Outcome of Imatinib-Intolerant Patients with Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Results From a European Observational Study (FORTE; CA180–211)

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML).

Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT

Polycomb Complex Group Gene Mutations and Their Prognostic Relevance In 5-Azacitidine Treated Myelodysplastic Syndrome Patients

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only